搜索筛选:
搜索耗时0.0938秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
发布年度:
Analysis of clinicopathological features of Chinese patients with advanced non-small cell lung cance
[会议论文] 作者：Yuan-Kai Shi,Yu-Tao Liu,Xue-Zhi Hao,Lin Wang,Xiao-Hong Han,Dan Li,Yu-Jie Zhou,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung c
[期刊论文] 作者：Pu-Yuan Xing,Jun-Ling Li,Yan Wang,Xue-Zhi Hao,Bin Wang,Lin Yang,Yuan-Kai Shi,
来源：中国癌症研究（英文版） 年份：2013
...
Analysis of clinicopathological features of Chinese patients with advanced non-small cell lung cance
[会议论文] 作者：Yuan-Kai Shi,Yu-Tao Liu,Xue-Zhi Hao,Lin Wang,Xiao-Hong Han,Dan Li,Yu-Jie Zhou,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: The echinoderm microtubule-associated protein-like4-anaplastic lymphoma kinase (EML4-ALK) fusion oncogene defines a novel molecular subset of non-small cell lung cancer(NSCLC).Crizotinib (X...
Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung c
[期刊论文] 作者：Pu-Yuan Xing,Jun-Ling Li,Yan Wang,Xue-Zhi Hao,Bin Wang,Lin Yang,Yuan-Kai Shi,Xiang-Ru Zhang,,
来源：Chinese Journal of Cancer Research 年份：2013
Objective: To observe the efficacy and safety of albumin-bound paclitaxel (ABP) monotherapy in treating recurrent advanced non-small-cell lung cancer (NSCLC). M...
Survival of patients with advanced lung adenocarcinoma before and after approved use of Gefitinib in
[会议论文] 作者：Yu-Tao Liu,Xiang-Ru Zhang,Yuan-Kai Shi,Xue-Zhi Hao,Jun-Ling Li,Xing-Sheng Hu,Yan Wang,Zi-Ping Wang,Hong-Yu,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Survival of patients with advanced lung adenocarcinoma before and after approved use of Gefitinib in
[会议论文] 作者：Yu-Tao Liu,Xiang-Ru Zhang,Yuan-Kai Shi,Xue-Zhi Hao,Jun-Ling Li,Xing-Sheng Hu,Yan Wang,Zi-Ping Wang,Hong-Yu,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: To compare the overall survival (OS) of patients with advanced lung adenocarcinoma before and after approved use of Gefitinib in China and to analyze the clinical factors that may affect OS...
Molecular detection of ALK rearrangement in selected non-small cell lung cancer: ALK expression prov
[会议论文] 作者：Ning-Ning Zhang,Sheng Yang,Peng Liu,Dan Li,Yu-Jie,Zhou Le Tang,Yuan-Kai Shi,Li Ma,Xue-Zhi Hao,Dong-Mei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Molecular detection of ALK rearrangement in selected non-small cell lung cancer: ALK expression prov
[会议论文] 作者：Ning-Ning Zhang,Sheng Yang,Peng Liu,Dan Li,Yu-Jie,Zhou Le Tang,Yuan-Kai Shi,Li Ma,Xue-Zhi Hao,Dong-Mei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: To elucidate the clinical significance of ALKrearrangement in selected advanced NSCLC patients and to evaluate a possible association between ALK expression and clinical outcomes in ALK-pos...
相关搜索：
